There is a growing demand for purified Omega-3’s such as EPA and DHA that goes beyond the purity of enriched products. There are applications in pharma and supplements / nutraceuticals.
Chromatography is the method of choice for the final purification step and operators need to improve their operating costs in order to compete. However this is generally a difficult separation of long carbon-chains compounds which are chemically very similar and increasing the injection surcharge quickly lead to a loss of resolution and the deterioration of performance.
With Inexiotech, the productivity of the stationary phase (KKD) and the eluant consumption (LK) are significantly improved, thereby reducing the OPEX. On a new-built facility the CAPEX of the purification plant can be reduced by a third.